4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-006995
See Remarks acquired 157,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sinha Vikas See Remarks | 2023-02-02 | Grant or award | +157,500 | 1,187,738 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Sinha Vikas See Remarks | 2023-02-02 | Grant or award · Stock Option (Right to Buy) | +292,500 | 1,012,362 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…